SonoVue与Sonazoid超声造影诊断化疗后结直肠癌肝转移的对比研究
前瞻性纳入2020年4月至2021年1月接受化疗后拟行肝切除的结直肠癌肝转移患者42例、348个肝脏局灶性病变(297个转移灶、51个非转移性病变),比较SonoVue与Sonazoid超声造影的诊断效能,以病理或术中超声联合MRI为参考标准。SonoVue诊断准确率64.7%优于Sonazoid的54.0%(P<.001),敏感度63.3%优于50.5%(P<.001),两者特异度72.5%与74.5%无显著差异(P=1.0)。
要点
- 化疗后结直肠癌肝转移中,SonoVue超声造影诊断准确率和敏感度均显著高于Sonazoid。
- Sonazoid延迟期和血管后期有40个转移灶呈非低增强而被误判为良性病变。
- 两种造影剂特异度相近,鉴别良性病变的假阳性风险相当。
核心结论
- 化疗后结直肠癌肝转移的诊断中,SonoVue超声造影表现显著优于Sonazoid。
研究设计与样本
- 前瞻性研究,纳入2020年4月至2021年1月化疗后拟行肝切除的结直肠癌肝转移患者42例、348个肝脏局灶性病变(297个转移灶、51个非转移性病变),以组织病理学或术中超声联合MRI为参考标准。
关键影像表现/征象
- Sonazoid超声造影延迟期和血管后期,40个转移灶呈非低增强(高增强或等增强),被误判为良性病变。
诊断标准与关键数值
- SonoVue诊断准确率64.7%、敏感度63.3%、特异度72.5%;Sonazoid诊断准确率54.0%、敏感度50.5%、特异度74.5%。
临床应用与阅片要点
- 化疗后结直肠癌肝转移的超声造影诊断中,SonoVue的诊断准确率和敏感度显著高于Sonazoid;Sonazoid延迟期和血管后期转移灶可呈非低增强而类似良性病变,判读时需注意。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the diagnostic efficacy of SonoVue and Sonazoid contrast-enhanced ultrasound (CEUS) in correctly detecting and characterizing colorectal liver metastasis (CRLM) after chemotherapy.
MATERIALS AND METHODS: Patients with CRLMs treated with chemotherapy and subsequently scheduled for hepatic resection were prospectively enrolled from April 2020 to January 2021. Lesions detected by SonoVue or Sonazoid CEUS were recorded as and characterized as metastases or non-metastatic lesions respectively. Histopathology or intraoperative ultrasound with MRI were the reference standard.
RESULTS: A total of 348 focal liver lesions in 42 patients were investigated, including 297 CRLMs and 51 non-metastatic lesions. SonoVue showed significantly higher diagnostic accuracy (64.7% versus 54.0%; P < .001) and sensitivity (63.3% versus 50.5%; P < .001) in the diagnosis of CRLMs than Sonazoid, both methods presented with similar specificity (72.5% versus 74.5%; P = 1.0). Forty metastases appeared non-hypoenhancing (hyperenhancing or isoenhancing) in the late phase and postvascular phase of Sonazoid CEUS and were mischaracterized as benign lesions.
CONCLUSION: SonoVue performed significantly better than Sonazoid in the diagnosis of CRLMs after chemotherapy.
引用
- Sun, Yin, Xing, et al. Contrast-Enhanced Ultrasound With SonoVue and Sonazoid for the Diagnosis of Colorectal Liver Metastasis After Chemotherapy. J Ultrasound Med. 2022. PMID: 35734885. doi:10.1002/jum.16042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。